What is the risk of annual recurrence for ICH classified using cerebral microbleeds (CMBs) as due to CAA?
In a recent pooled analysis of observational studies, patients with ICH classi ed using CMBs as due to CAA had an approximately 7% annual recurrence risk, compared with about 1% for those not ful lling criteria for CAA.